Maturation of pluripotent stem cell-derived cardiomyocytes: limitations and challenges from metabolic aspects

Maturation of pluripotent stem cell-derived cardiomyocytes: limitations and challenges from metabolic aspects

Abstract Acute coronary syndromes, such as myocardial infarction (MI), lack effective therapies beyond heart transplantation, which is often hindered by donor scarcity and postoperative complications. Human induced pluripotent stem cells (hiPSCs) offer the possibility of myocardial regeneration by d...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Xi Jiang, Xin Lian, Kun Wei, Jie Zhang, Kaihua Yu, Haoming Li, Haichun Ma, Yin Cai, Lei Pang
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	BMC 2024-10-01
Reeks:	Stem Cell Research & Therapy
Onderwerpen:	Acute coronary syndromes Myocardial infarction Induced pluripotent stem cells iPSC-cardiomyocytes Maturation Energy metabolism
Online toegang:	https://doi.org/10.1186/s13287-024-03961-4

Gelijkaardige items

Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse
door: Peng Wu, et al.
Gepubliceerd in: (2023-02-01)

Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling
door: Sofija Vučković, et al.
Gepubliceerd in: (2022-07-01)

iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development
door: Eline Simons, et al.
Gepubliceerd in: (2023-01-01)

Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
door: Jiangtao Li, et al.
Gepubliceerd in: (2022-06-01)

Metabolic Maturation Exaggerates Abnormal Calcium Handling in a <i>Lamp2</i> Knockout Human Pluripotent Stem Cell-Derived Cardiomyocyte Model of Danon Disease
door: Robert J. Barndt, et al.
Gepubliceerd in: (2022-12-01)

Disease Modeling of Mitochondrial Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells
door: Takeshi Tokuyama, et al.
Gepubliceerd in: (2021-09-01)

Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes
door: Francis Grafton, et al.
Gepubliceerd in: (2021-08-01)

Cardiac repair in a murine model of myocardial infarction with human induced pluripotent stem cell-derived cardiomyocytes
door: Xin Jiang, et al.
Gepubliceerd in: (2020-07-01)

Activation of AMPK Promotes Maturation of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
door: Liang Ye, et al.
Gepubliceerd in: (2021-03-01)

Action potential variability in human pluripotent stem cell-derived cardiomyocytes obtained from healthy donors
door: A. B. Carvalho, et al.
Gepubliceerd in: (2022-12-01)

The role and mechanism of NRG1/ErbB4 in inducing the differentiation of induced pluripotent stem cells into cardiomyocytes
door: Xiaoou Li, et al.
Gepubliceerd in: (2024-10-01)

Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction
door: Yang Xiao, et al.
Gepubliceerd in: (2022-08-01)

Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes
door: Jingjun Zhou, et al.
Gepubliceerd in: (2023-04-01)

Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes
door: Rou Chen, et al.
Gepubliceerd in: (2019-03-01)

Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
door: Jin-he Jiang, et al.
Gepubliceerd in: (2024-01-01)

Impaired Relaxation in Induced Pluripotent Stem Cell‐Derived Cardiomyocytes with Pathogenic TNNI3 Mutation of Pediatric Restrictive Cardiomyopathy
door: Renjie Wang, et al.
Gepubliceerd in: (2024-03-01)

Incomplete Assembly of the Dystrophin-Associated Protein Complex in 2D and 3D-Cultured Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
door: Guillaume Gilbert, et al.
Gepubliceerd in: (2021-11-01)

Rock inhibitor may compromise human induced pluripotent stem cells for cardiac differentiation in 3D
door: Bin Jiang, et al.
Gepubliceerd in: (2022-03-01)

Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments
door: Yoshikazu Kishino, et al.
Gepubliceerd in: (2023-03-01)

In vitro maturation of human pluripotent stem cell-derived cardiomyocyte: A promising approach for cell therapy
door: Yun-Gwi Park, et al.
Gepubliceerd in: (2022-06-01)

In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts
door: Shin Kadota, et al.
Gepubliceerd in: (2017-02-01)

ELM2‐SANT Domain‐Containing Scaffolding Protein 1 Regulates Differentiation and Maturation of Cardiomyocytes Derived From Human‐Induced Pluripotent Stem Cells
door: Yu‐An Lu, et al.
Gepubliceerd in: (2024-07-01)

Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes
door: Yuichi Horikoshi, et al.
Gepubliceerd in: (2019-09-01)

Genetic and Pharmacological YAP Activation Induces Proliferation and Improves Survival in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
door: Thuy Anh Bui, et al.
Gepubliceerd in: (2023-08-01)

Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes
door: Hao Yang, et al.
Gepubliceerd in: (2023-08-01)

Temporal Control of the WNT Signaling Pathway During Cardiac Differentiation Impacts Upon the Maturation State of Human Pluripotent Stem Cell Derived Cardiomyocytes
door: Chantelle Tsoi, et al.
Gepubliceerd in: (2022-03-01)

Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene
door: Omer Hatim, et al.
Gepubliceerd in: (2023-12-01)

Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
door: Sherida de Leeuw, et al.
Gepubliceerd in: (2019-07-01)

Follistatin-like 1 promotes proliferation of matured human hypoxic iPSC-cardiomyocytes and is secreted by cardiac fibroblasts
door: Marijn C. Peters, et al.
Gepubliceerd in: (2022-06-01)

iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects
door: Chithra K. Pushpan, et al.
Gepubliceerd in: (2024-08-01)

Impact of Neurons on Patient-Derived Cardiomyocytes Using Organ-On-A-Chip and iPSC Biotechnologies
door: Albin A. Bernardin, et al.
Gepubliceerd in: (2022-11-01)

Three-dimensional cardiac organoid formation accelerates the functional maturation of human induced pluripotent stem cell-derived cardiomyocytes
door: Hanbyeol Lee, et al.
Gepubliceerd in: (2022-05-01)

Sarcomere Disassembly and Transfection Efficiency in Proliferating Human iPSC-Derived Cardiomyocytes
door: Qianliang Yuan, et al.
Gepubliceerd in: (2022-01-01)

How can we use stem cell-derived cardiomyocytes to understand the involvement of energetic metabolism in alterations of cardiac function?
door: Sabine Rebs, et al.
Gepubliceerd in: (2023-09-01)

Do Human iPSC-Derived Cardiomyocytes Cultured on PLA Scaffolds Induce Expression of CD28/CTLA-4 by T Lymphocytes?
door: David Sergeevichev, et al.
Gepubliceerd in: (2022-01-01)

Co-transplantation of Mesenchymal Stromal Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes Improves Cardiac Function After Myocardial Damage
door: Klaus Neef, et al.
Gepubliceerd in: (2022-01-01)

Increasing the physical size and nucleation status of human pluripotent stem cell-derived ventricular cardiomyocytes by cell fusion
door: Chi-Wing Kong, et al.
Gepubliceerd in: (2017-03-01)

Polymerized Laminin-521: A Feasible Substrate for Expanding Induced Pluripotent Stem Cells at a Low Protein Concentration
door: Fernanda C. P. Mesquita, et al.
Gepubliceerd in: (2022-12-01)

Three-Dimensional Poly-(ε-Caprolactone) Nanofibrous Scaffolds Promote the Maturation of Human Pluripotent Stem Cells-Induced Cardiomyocytes
door: Mingming Zhang, et al.
Gepubliceerd in: (2022-08-01)

Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation
door: Bernardo Bonilauri, et al.
Gepubliceerd in: (2023-10-01)